Warnecke-Eberz et al. showed that ERCC1 mRNA expression was prognostic for histopathologic response to neoadjuvant radiochemotherapy involving cisplatin in patients with locally advanced esophageal cancer in combination with surgical tumor removal [24]. This evidence concerns the gene ERCC1 and neoplasm.